ECSP034578A - INDOLILMALEIMIDE DERIVATIVES AS CINASE C PROTEIN INHIBITORS C - Google Patents
INDOLILMALEIMIDE DERIVATIVES AS CINASE C PROTEIN INHIBITORS CInfo
- Publication number
- ECSP034578A ECSP034578A ECSP034578A ECSP034578A EC SP034578 A ECSP034578 A EC SP034578A EC SP034578 A ECSP034578 A EC SP034578A EC SP034578 A ECSP034578 A EC SP034578A
- Authority
- EC
- Ecuador
- Prior art keywords
- derivatives
- indolilmaleimide
- cinase
- protein inhibitors
- indolylmaleiide
- Prior art date
Links
- 229940121649 protein inhibitor Drugs 0.000 title 1
- 239000012268 protein inhibitor Substances 0.000 title 1
- 208000030090 Acute Disease Diseases 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 206010052779 Transplant rejections Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037976 chronic inflammation Diseases 0.000 abstract 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 125000005956 isoquinolyl group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000005493 quinolyl group Chemical group 0.000 abstract 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Los derivados de indolilmaleiida que comprenden un residuo de fenilo sustituido, naftilo, tetrahidronaftilo, quinazolinilo, quinolilo, isoquinolilo, o pirirnidinilo, tienen interesantes propiedades farmacéuticas, por ejemplo en el tratamiento y/o en la prevención de enfermedades o desórdenes inflamatorios agudos o crónicos mediados por células T, enfermedades auto inmunes, rechazo de injertos, o cáncerIndolylmaleiide derivatives comprising a substituted phenyl residue, naphthyl, tetrahydronaphthyl, quinazolinyl, quinolyl, isoquinolyl, or pyrirnidinyl, have interesting pharmaceutical properties, for example in the treatment and / or in the prevention of acute or chronic inflammatory diseases or disorders. for T cells, autoimmune diseases, graft rejection, or cancer
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24640000P | 2000-11-07 | 2000-11-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034578A true ECSP034578A (en) | 2003-06-25 |
Family
ID=33449385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP034578 ECSP034578A (en) | 2000-11-07 | 2003-05-07 | INDOLILMALEIMIDE DERIVATIVES AS CINASE C PROTEIN INHIBITORS C |
Country Status (3)
| Country | Link |
|---|---|
| EC (1) | ECSP034578A (en) |
| NO (1) | NO20071232L (en) |
| ZA (1) | ZA200303426B (en) |
-
2003
- 2003-05-05 ZA ZA200303426A patent/ZA200303426B/en unknown
- 2003-05-07 EC ECSP034578 patent/ECSP034578A/en unknown
-
2007
- 2007-03-06 NO NO20071232A patent/NO20071232L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200303426B (en) | 2004-04-22 |
| NO20071232L (en) | 2003-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP104578A (en) | INDOLILMALEIMIDA DERIVATIVES AS CINASE C PROTEIN INHIBITORS C | |
| CY1110177T1 (en) | Z-CARBONYLSYL SUBSTITUTED BISINSULARS AS RAF MOTION INHIBITORS | |
| CY1116107T1 (en) | COMPOSITIONS FOR USE IN THE TREATMENT OF AUTOMATIC DISEASES, IMMUNO-ALLERGIC DISEASES AND REJECTION OF ORGAN OR TISSUE TRANSFUSION | |
| DK1419154T3 (en) | Rapamycin 29-enols | |
| CY1113160T1 (en) | ARYLURIA COMPOUNDS IN CONNECTION WITH OTHER CELLULAR OR CELLULAR MEDICINES FOR HUMAN CANCER TREATMENT | |
| MX2021004775A (en) | EXPANSION OF TUMOR-INFILTRATING LYMPHOCYTES (TILS) USING INHIBITORS OF THE PROTEIN KINASE B PATHWAY (AKT). | |
| CY1105286T1 (en) | O-CARBOXYARYLYPOsubstituted BINYLUREAS AS RAF KINASE INHIBITORS | |
| NO20005224D0 (en) | BTK inhibitors and methods for their identification and use | |
| ATE411321T1 (en) | WATER SOLUBLE RAPAMYCIN ESTERS | |
| PT1605956E (en) | ADMINISTRATION OF CAPSAICINOIDS FOR THE TREATMENT OF OSTEOARTRITE | |
| DK1539166T3 (en) | Pharmaceutical compositions containing dextromethorphan and quinidine for the treatment of neurological disorders | |
| ES2572454T3 (en) | Treatment of diseases mediated by T lymphocytes | |
| CY1115745T1 (en) | COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF OXALIC DISEASES | |
| EP1513825A4 (en) | ANTI-TUBERCULOUS DRUG: COMPOSITIONS AND METHODS | |
| EP1578373A4 (en) | NEW COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH THE IMMUNE SYSTEM | |
| SE0302304D0 (en) | Novel compounds | |
| DK1220852T3 (en) | Substituted diazepanes | |
| NO20030579L (en) | Vascular grafts and methods for implanting them | |
| UY28049A1 (en) | DERIVATIVES OF (6,7-DIHIDRO-5H-IMIDAZO (1,2-A) IMIDAZOL-3-SULPHONYLAMINE) -PROPIONAMIDE | |
| ITMI20030897A1 (en) | PROCEDURE AND EQUIPMENT FOR FRACTIONING BLOOD. | |
| BRPI0409475A (en) | vav inhibition in graft rejection | |
| IT1318401B1 (en) | N-DESACETYLTHIOCOLCHYCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN. | |
| CY1106540T1 (en) | 3-POSITION HETEROCYL SUBSTITUTED PIPERIDINO-2,6-DIONES | |
| DK0889721T3 (en) | Drug for exterior use and application of an aqueous oil emulsion to such a drug | |
| ATE545421T1 (en) | PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF TROPICAL PARASITIC DISEASES CONTAINING DIMINAZEN DI-ACETURATE |